All News
ANA variability among different platforms and essays.
Validated quantification test are needed!!
Peter Lipsky @rhumnow #rnl2022 https://t.co/pyJhBkJE8P
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Top Influencers of #RNL2022: @doctorRBC @hausmannMD @RheumNow @uptoTate @NoufAhmedAlham2 @Janetbirdope More 📊 https://t.co/5tIzMLfqrh
Symplur Hashtags healthhashtags ( View Tweet)
Dr. Kavanaugh reviews the process of guidelines/recommendations. It's a lot of work! #RNL2022 @RWCSmtg @RheumNow https://t.co/z48mVKweVq
Dr. Rachel Tate uptoTate ( View Tweet)
POD 3 on Psoriatic Arthritis Advances will begin at 2pm ET and Dr. Artie Kavanaugh will lead the first presentation of the pod titled PsA Guidelines: The Good, Bad & Ugly. #RNL2022 https://t.co/cx3XBSWbNr
Dr. John Cush RheumNow ( View Tweet)
Anifrolumab high incidence of herpes zoster #RNL2022
madan madanpadmajan1 ( View Tweet)
Dr. Narain: SLE flare risk w/ HCQ tapering/reducing dose vs maintaining.
Retinopathy risk:
💎doubles every 5 yrs of use
💎^ w/ ^ dosing per ABW
💎^ w/ IBW in dose-response manner
💎independent risk factors: cumulative HCQ use, duration of use, CKD, Asian decent #RNL2022 @RheumNow https://t.co/lgMNEmQEhl
Dr. Rachel Tate uptoTate ( View Tweet)
Interesting potential upcoming SLE treatments
Data from China
Improvement of SRI-4 response rate compared to placebo
@RheumNow #RNL2022 https://t.co/VE5Tza7xt8
Robert B Chao, MD doctorRBC ( View Tweet)
Anifrolumab and lupus.
Don not forget Herpes zoster vaccination!!
Sonail Narain @RheumNow #Rnl2022 https://t.co/hNWaSHH27d
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
#ClinicalPearl Maybe..2 approaches that may Rx #SLE. More data needed but restoring IL2 or use of Telitacept latter w BLyS & APRIL effects (B cell signalling) #RNL2022 @RheumNow https://t.co/qjHZH9Xg0k
Janet Pope Janetbirdope ( View Tweet)
Safety in pregnancy still not clear #RNL2022 https://t.co/xs8bxja2VX
madan madanpadmajan1 ( View Tweet)
Great talk by Sonail Narain at #Rnl2022 @RheumNow
Take home message!! https://t.co/rT8WNPRtvB
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Targeting the BLyS-APRIL signaling pathway in SLE
Sonail Narain @RheumNow #Rnl2022 https://t.co/g3MbO4swKy
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Role of Anti-CD-19 CAR-T therapy in treatment of refractory SLE?
Case reports only thus far
@RheumNow #RNL2022 https://t.co/0dIid7viZ5
Robert B Chao, MD doctorRBC ( View Tweet)
“Physician global impression on RA control changes DMARD prescription, while patient global changes DMARD adherence” —Dr. Michaud #RNL2022
Ara Dikranian RumorDoc ( View Tweet)
Emphasizing what we should know. Do not stop or decrease HCQ - associated with SLE flares
@RheumNow #RNL2022 https://t.co/ko37cBOQPF
Robert B Chao, MD doctorRBC ( View Tweet)
Great presentation by Dr. Narain on Novel Treatment of SLE #RNL2022 https://t.co/l9LyH1oPhd
Dr. John Cush RheumNow ( View Tweet)
Poor prognostic factors and mortality in lupus and lupus nephritis.
Joan Merrill @RheumNow #Rnl2022 https://t.co/j6mn87f7QJ
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Plaquenil
▶️Immune system
Effect on toll like receptor and interferon production.
▶️ Effect on mortality
Decrease it.
▶️ Metabolic
Anti platelet , anti diabetic and anti lipid.
▶️Pregnancy
Decrease transmission of Anti Ro to baby
@RheumNow #Rnl2022
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Be aware of "Lupus podocytopathy"
non-immune complex mediated nephritis
can be similar to minimal change disease
may respond to immunosuppression
@RheumNow #RNL2022
Robert B Chao, MD doctorRBC ( View Tweet)
Could combination therapy from get go, work?!
Joan Merrill @RheumNow #Rnl2022 https://t.co/m1Mt78J4RX
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)